Viennese hospitals to improve cancer treatment with Elekta equipment and software

VIENNA, Austria, July 18, 2016 - The Vienna Hospital Association (Wiener Krankenanstaltenverbund) has chosen to treat its cancer patients with advanced solutions from Elekta’s (EKTA-B.ST) radiation therapy and software portfolio. The deal will include four Versa HD and two Elekta Infinity linear accelerators, brachytherapy afterloaders, MOSAIQ oncology information system and Monaco treatment planning system, as well as long-term service contracts.

The equipment and software will be installed at two new radiation oncology departments situated in Vienna: Hietzing Hospital (KHR) and Sozialmedizinisches Zentrum Ost - Donauspital (SZO) in a long-term public-private partnership contract. All equipment and software will be delivered over the next 24 months.

Ian Alexander, Chief Commercial Officer at Elekta, says that this significant order underpins Elekta’s leading market position in Austria on a long-term basis. ”Almost 40,000 people are diagnosed with cancer in Austria each year and it’s the second most common cause of death in the country. Studies have proven that radiation therapy is an effective treatment for cancer, even if it cannot save every patient. We are grateful to be able to make an impact on these statistics and the patients at the Vienna Hospital Association by improving or saving lives.”

The Vienna Hospital Association, which includes all hospitals and geriatric centers in the City of Vienna, is one of the largest hospital operators in Europe. The Association will purchase the Elekta equipment and software through VAMED, a leading international company in the field of planning, building, and managing complex public health care facilities. Elekta will act as a subcontractor to VAMED.

The order was signed and booked during the first quarter of Elekta’s fiscal year 2016/17. The first shipment of equipment is scheduled for May 2017.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com 
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on July 18, 2016.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.

Tags:

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Subscribe

Documents & Links